STARTUP/TECHNOLOGY
RPG LS Transfers API Business To Its Arm, InvAscent To Invest ₹243 Cr
RPG Life Sciences Ltd (RPG LS) has executed a Business Transfer Agreement to transfer its Active Pharmaceutical Ingredients (API) business to its wholly owned subsidiary, RPG Active Pharma Ltd, on a slump sale basis as a going concern. The restructuring is part of the company’s strategy to create a focused API business with dedicated capital, […]
CW Bureau
·
Jul 30, 2026
BANKING & FINANCE
Neo Group Secures ₹350 Cr In New Funding Led By Peak XV Partners
Integrated wealth and asset management platform Neo Group has signed definitive agreements to raise approximately ₹350 crore in a funding round led by Peak XV Partners, reinforcing investor confidence as the company accelerates its next phase of expansion. The latest investment marks a deeper commitment from Peak XV Partners, Neo Group’s earliest institutional investor. The […]
CW Bureau
·
Jul 16, 2026
BANKING & FINANCE
Neo Asset Closes ₹1,000 Cr Real Asset Yield Fund In Under 5 Months
Neo Asset has achieved the final close of its Neo Real Asset Yield Fund at its target corpus of ₹1,000 crore, completing the fundraising in less than five months. The open-ended Category III Alternative Investment Fund (AIF) invests across privately and publicly listed Real Estate Investment Trusts (REITs) and Infrastructure Investment Trusts (InvITs). The company […]
CW Bureau
·
Jul 6, 2026
RETAIL/FMCG
RBI Clears Bain Capital’s Joint Control In Manappuram Subsidiaries
Manappuram Finance Ltd on Thursday said its subsidiaries, Asirvad Micro Finance Ltd (AMFL) and Manappuram Home Finance Ltd (MHFL), have received approvals from the Reserve Bank of India for an indirect change in control and management by affiliates of Bain Capital. The regulatory clearances mark a key milestone in the proposed strategic investment, which is […]
CW Bureau
·
Mar 19, 2026
GENERAL
ChrysCapital To Buy Novartis India 70.68% Equity Stake For ₹1,446 Cr
Swiss pharmaceutical major Novartis AG has entered into a definitive agreement with private equity firm ChrysCapital to divest its entire stake in its Indian subsidiary to a consortium comprising WaveRise Investments Ltd, ChrysCapital Fund X and Two Infinity Partners. On February 19, Novartis India Ltd signed a share purchase agreement to sell around 1.75 crore […]
CW Bureau
·
Feb 20, 2026
